Capstone Investment Advisors
VIVO

Capstone Investment Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Capstone Investment Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,532
Closed -$361K – 949
2016
Q2 		$361K Buy
+18,532
New +$363K 0.01% 538

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Capstone Investment Advisors's VIVO Position: Q3 2016 in Review

Capstone Investment Advisors sold out of Meridian Bioscience Inc (VIVO) in Q3 2016, closing a stake of 18,532 shares — an estimated $361K sold.

Capstone Investment Advisors first reported a position in VIVO in Q2 2016 and held it in 1 quarter. The position peaked at $361K in Q2 2016. 173 funds tracked by Wall St. Rank hold VIVO as of Q3 2016.

  • Capstone Investment Advisors reported no remaining Meridian Bioscience Inc position as of Q3 2016 after selling out during the quarter.
  • Capstone Investment Advisors sold 18,532 Meridian Bioscience Inc shares in Q3 2016, an estimated $361K.
  • Capstone Investment Advisors first reported a position in Meridian Bioscience Inc in Q2 2016 and held it in 1 quarter.
  • Capstone Investment Advisors's Meridian Bioscience Inc position peaked at $361K in Q2 2016.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2016.

Based on Capstone Investment Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.